These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 18648727
41. A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine. Romeo E, Grimaldi N, Sarubbi B, D'Alto M, Santarpia G, Scognamiglio G, Russo MG, Calabrò R. Pediatr Cardiol; 2011 Aug; 32(6):842-5. PubMed ID: 21479666 [Abstract] [Full Text] [Related]
42. A comparative study of ivabradine and atenolol in patients with moderate mitral stenosis in sinus rhythm. Rajesh GN, Sajeer K, Sajeev CG, Bastian C, Vinayakumar D, Muneer K, Haridasan V, Mathew D, George B, Krishnan MN. Indian Heart J; 2016 Aug; 68(3):311-5. PubMed ID: 27316483 [Abstract] [Full Text] [Related]
43. Ivabradine to treat inappropriate sinus tachycardia after the fast pathway ablation in a patient with severe pectus excavatum. Capulzini L, Sarkozy A, Semeraro O, Paparella G, Chierchia GB, DE Asmundis C, Roos M, Yazaki Y, Muller-Burri A, Sorgente A, Brugada P. Pacing Clin Electrophysiol; 2010 Mar; 33(3):e32-5. PubMed ID: 19821934 [Abstract] [Full Text] [Related]
44. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction. Perry CM. Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944 [Abstract] [Full Text] [Related]
45. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study. Bagriy AE, Schukina EV, Samoilova OV, Pricolota OA, Malovichko SI, Pricolota AV, Bagriy EA. Adv Ther; 2015 Feb 01; 32(2):108-19. PubMed ID: 25700807 [Abstract] [Full Text] [Related]
47. Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study. Xu X, Guo Y, Gao W, Huang M, Liu T, Li F. Eur J Pediatr; 2023 May 01; 182(5):2265-2271. PubMed ID: 36869903 [Abstract] [Full Text] [Related]
48. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study]. Hu DY, Huang DJ, Yuan ZY, Zhao RP, Yan XW, Wang MH, Chinese Investigators of SHIFT Study. Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar 24; 45(3):190-197. PubMed ID: 28316174 [Abstract] [Full Text] [Related]
49. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina. Amosova E, Andrejev E, Zaderey I, Rudenko U, Ceconi C, Ferrari R. Cardiovasc Drugs Ther; 2011 Dec 24; 25(6):531-7. PubMed ID: 21830063 [Abstract] [Full Text] [Related]
51. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Calò L, Rebecchi M, Sette A, Martino A, de Ruvo E, Sciarra L, De Luca L, Zuccaro LM, Giunta G, Ciccaglioni A, Lioy E, Fedele F. Heart Rhythm; 2010 Sep 24; 7(9):1318-23. PubMed ID: 20621618 [Abstract] [Full Text] [Related]
52. The use of ivabradine in a patient with inappropriate sinus tachycardia and cardiomyopathy due to limb girdle muscular dystrophy type 2I. Rajendram R, AlDhahri F, Mahmood N, Kharal M. BMJ Case Rep; 2020 Jan 21; 13(1):. PubMed ID: 31969397 [Abstract] [Full Text] [Related]
53. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Camm AJ, Lau CP. Drugs R D; 2003 Jan 21; 4(2):83-9. PubMed ID: 12718562 [Abstract] [Full Text] [Related]
54. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C. Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003 [Abstract] [Full Text] [Related]
55. Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine. Sağ S, Çoşkun H, Baran İ, Güllülü S, Aydınlar A. Anatol J Cardiol; 2016 Mar 06; 16(3):212-3. PubMed ID: 27067557 [No Abstract] [Full Text] [Related]
56. Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients. Bonadei I, Sciatti E, Vizzardi E, Fabbricatore D, Pagnoni M, Rossi L, Carubelli V, Lombardi CM, Metra M. Cardiovasc Ther; 2018 Jun 06; 36(3):e12323. PubMed ID: 29460403 [Abstract] [Full Text] [Related]
57. Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine. Bohora S, Lokhandwala Y, Parekh P, Vasavda A. J Cardiovasc Electrophysiol; 2011 Mar 06; 22(3):340-2. PubMed ID: 20653812 [Abstract] [Full Text] [Related]
58. A case of atrial tachycardia treated with ivabradine as bridge to ablation. Meles E, Carbone C, Maggiolini S, Moretti P, DE Carlini CC, Gentile G, Gnecchi-Ruscone T. J Cardiovasc Electrophysiol; 2015 May 06; 26(5):565-8. PubMed ID: 25656911 [Abstract] [Full Text] [Related]
59. The effect of ivabradine on functional capacity in patients with chronic obstructive pulmonary disease. Mahmoud K, Kassem HH, Baligh E, ElGameel U, Akl Y, Kandil H. Clin Med (Lond); 2016 Oct 06; 16(5):419-422. PubMed ID: 27697801 [Abstract] [Full Text] [Related]
60. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial. Komajda M, Isnard R, Cohen-Solal A, Metra M, Pieske B, Ponikowski P, Voors AA, Dominjon F, Henon-Goburdhun C, Pannaux M, Böhm M, prEserveD left ventricular ejectIon fraction chronic heart Failure with ivabradine studY (EDIFY) Investigators. Eur J Heart Fail; 2017 Nov 06; 19(11):1495-1503. PubMed ID: 28462519 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]